Trial Profile
An Open-label, Single Arm, Sequential, Single Centre Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2020
Price :
$35
*
At a glance
- Drugs Semaglutide (Primary) ; Digoxin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 04 Apr 2019 Results investigating the effect of oral semaglutide on the pharmacokinetics of lisinopril, warfarin, digoxin, and metformin using two one sequence crossover trials (NCT02249910 and NCT02249910) published in the Clinical Pharmacokinetics
- 15 Sep 2017 Results assessing the effect of oral semaglutide on the pharmacokinetic properties of metformin and digoxin, presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes.
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association